NorthWest Biotherapeutics Inc (NWBO)

[dstock07734]

Ex,
Do you have commonsense? Or are you pretending being stupid to mislead the longs?

If RevImmune ever used DCs in any trials, it must be DCVax-L. Should that be simple enough to understand? You don't mean RevImmune was trying develop another type of DC vaccine while knowing there was one handy which had been proven working for GBM.

It doesn't matter how many years ago. It matters why RevImmune can get the sponsorship from NCI and the French government. Did you see in February RevImmune was listed among the task force on rare diseases by the French government? It is all because of the unique data from the company that put the company on the list.